Harvard Bioscience (HBIO) Net Cash Flow Growth (1y) (2011 - 2026)
Harvard Bioscience (HBIO) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 127.11 Bn | 121.89 Bn | 1.96 Bn | -9.88% |
| 2 | Becton Dickinson | 44.95 Bn | 44.14 Bn | 2.15 Bn | 131.47% |
| 3 | Alcon | 33.17 Bn | 31.51 Bn | 1.53 Bn | - |
| 4 | Medline | 32.85 Bn | 30.61 Bn | 1.84 Bn | -47.85% |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn | -40.20% |
| 6 | West Pharmaceutical Services | 23.33 Bn | 22.89 Bn | 329.20 Mn | -196.55% |
| 7 | Solventum | 14.10 Bn | 13.54 Bn | 1.10 Bn | -41.07% |
| 8 | Cooper Companies | 13.83 Bn | 13.69 Bn | 735.40 Mn | 102.38% |
| 9 | Align Technology | 12.05 Bn | 10.99 Bn | 736.59 Mn | 84.02% |
| 10 | Harvard Bioscience | 26.84 Mn | 19.74 Mn | 12.24 Mn | -217.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -217.47% |
| Dec 31, 2025 | 1,889.80% |
| Sep 30, 2025 | -458.94% |
| Jun 30, 2025 | 699.05% |
| Mar 31, 2025 | 793.50% |
| Dec 31, 2024 | 88.79% |
| Sep 30, 2024 | -87.52% |
| Jun 30, 2024 | -138.22% |
| Mar 31, 2024 | 115.51% |
| Dec 31, 2023 | -205.59% |
| Sep 30, 2023 | 107.19% |
| Jun 30, 2023 | 145.62% |
| Mar 31, 2023 | 66.44% |
| Dec 31, 2022 | -112.15% |
| Sep 30, 2022 | 189.43% |
| Jun 30, 2022 | -427.03% |
| Mar 31, 2022 | 1.75% |
| Dec 31, 2021 | -57.47% |
| Sep 30, 2021 | -916.25% |
| Jun 30, 2021 | 111.53% |